Tirzepatide


Tirzepatide is a novel medication that is FDA approved for the treatment of type 2 diabetes mellitus. It is composed of 39 amino acids and is an analog of the gastric inhibitory polypeptide. Given its potent weight loss properties, Tirzepatide can be used for obesity treatment. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as Semaglutide, and is given as a once-a-week subcutaneous injectable. The FDA approved Tirzepatide in May 2022. The main difference between Semaglutide and Tirzepatide is that Tirzepatide activates two hormone receptors – GLP-1 and GIP – while Semaglutide only activates GLP-1. This may give Tirzepatide a greater effect on blood glucose, appetite, and weight loss.


Make an appointment

Tirzepatide Shot

Core IV now offers Tirzepatide shots to assist patients who are trying to achieve weight loss goals. Tirzepatide is also known as Mounjoro, but we are offering our own compound.

What is a Tirzepatide shot?

At Core IV we are offering Tirzepatide to help unlocks the power of weight loss. It was developed with cutting-edge technology that works on two receptors at the same time instead of only one. Tirzepatide has been backed by rigorous clinical research, and is a game-changer in weight loss because its unique blend of ingredients helps to curb cravings, increase metabolism, helps you feel fuller longer which promote healthy weight loss, making it the perfect solution for those who want to achieve their weight loss goals quickly and effectively. Tirzepatide, can help you be on your way to a healthier, happier you in no time.

Dosing Schedule:


Week 1 through Week 4              2.5 mg once weekly            2.5 mg        $200/shot      Package of 4  $720

Week 2 through Week 8               5 mg once weekly                5 mg           $300/shot      Package of 4  $1,080

Week 9 through week 12              7.5 mg once weekly            7.5 mg        $400/shot      Package of 4  $1,440

Week 13 through week 16           10 mg once weekly              10 mg         $500/shot      Package of 4  $1,800

Week 17 through week 20           12.5 mg once weekly           12.5 mg     $600/shot      Package of 4  $2,160

Week 21 through week 24           15 mg once weekly               15 mg        $700/shot      Package of 4  $2,520

Most Common Side effects include:

Nausea

Vomiting

Diarrhea

Decreased Appetite

Constipation

Abdominal Pain

How does Tirzepatide differ from Mounjoro?


Mounjoro is the brand name, whereas Tirzepatide is the name of the actual medication itself. As a result, the effects are basically the same.


Tirzepatide Contraindications

Patients should be aware of the following contraindications. If either of these conditions have been recorded in either your personal history or your family history, you should avoid taking Tirzepatide:

Medullary Thyroid Cancer

Multiple Endocrine Neoplasia Syndrome Type 2





Get in touch

Contact us now

Our services do not take the place of your physician’s advice. These statements have not been evaluated by the FDA. As with any new treatment, please consult your physician if you have any concerns or to see if this is right for you.


CONTACT

Free call 24/7
+1-866-4 CORE iV





Follow us

Our Activity

Organically grow the holistic world view of innovation empowerment.



Copyright © 2021 Core IV Therapy, LLC | All Rights Reserved.